Skip to main content
Erschienen in: International Journal of Clinical Oncology 6/2011

01.12.2011 | Case Report

A case of enteropathy-associated T-cell lymphoma: diagnosis by flow cytometric immunophenotyping and genome analysis using ascitic fluid

verfasst von: Masako Nishimura, Kenjiro Tomo

Erschienen in: International Journal of Clinical Oncology | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Enteropathy-associated T-cell lymphoma (ETCL) is a primary extranodal T-cell lymphoma arising in the gastrointestinal tract, and is known as a rare and highly aggressive disease with a poor prognosis. The diagnosis of ETCL is usually established by histological examination using resected tumors or biopsy specimens during endoscopic studies. If tumor specimens for histopathological investigation are not available, then such a case might be difficult to accurately diagnose. We report here a case of ETCL which was diagnosed by cytopathology and flow cytometric immunophenotyping using paracentesis fluid without tumor specimens. Immunophenotyping by flow cytometry (FCM) of the ascitic fluid (AF) was invaluable in the final diagnosis of ETCL. Moreover, genetic alterations in the current case were also demonstrated. We emphasize the usefulness of effusion cytology for the expeditious diagnosis of ETCL. In particular, even in cases without tumor specimens, immunophenotyping by FCM using AF can play an important role in the diagnosis of ETCL, and simultaneous genome analysis may be useful to elucidate the biological characteristics of ETCL.
Literatur
1.
Zurück zum Zitat Lymphoma Study Group of Japanese Pathologists (2000) The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int 50:696–702CrossRef Lymphoma Study Group of Japanese Pathologists (2000) The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int 50:696–702CrossRef
2.
Zurück zum Zitat Chott A, Dragosics B, Radaszkiewicz T (1992) Peripheral T-cell lymphomas of the intestine. Am J Pathol 141:1361–1371PubMed Chott A, Dragosics B, Radaszkiewicz T (1992) Peripheral T-cell lymphomas of the intestine. Am J Pathol 141:1361–1371PubMed
3.
Zurück zum Zitat Isaacson PG (1999) Gastrointestinal lymphoma of T- and B-cell types. Mod Pathol 12:151–158PubMed Isaacson PG (1999) Gastrointestinal lymphoma of T- and B-cell types. Mod Pathol 12:151–158PubMed
4.
Zurück zum Zitat Kohno S, Ohshima K, Yoneda S et al (2003) Clinicopathological analysis of 143 primary malignant lymphomas in the small and large intestines based on the new WHO classification. Histopathology 43:135–143PubMedCrossRef Kohno S, Ohshima K, Yoneda S et al (2003) Clinicopathological analysis of 143 primary malignant lymphomas in the small and large intestines based on the new WHO classification. Histopathology 43:135–143PubMedCrossRef
5.
Zurück zum Zitat Zettl A, Deleeuw R, Haralambieva E et al (2007) Enteropathy-type T-cell lymphoma. Am J Clin Pathol 127:701–706PubMedCrossRef Zettl A, Deleeuw R, Haralambieva E et al (2007) Enteropathy-type T-cell lymphoma. Am J Clin Pathol 127:701–706PubMedCrossRef
6.
Zurück zum Zitat Spencer J, Cerf-Bensussan N, Jarry A et al (1988) Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol 132:1–5PubMed Spencer J, Cerf-Bensussan N, Jarry A et al (1988) Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol 132:1–5PubMed
8.
Zurück zum Zitat Chott A, Haedicke W, Mosberger I et al (1998) Most CD56+ intestinal lymphomas are CD8+ CD5− T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol 153:1483–1490PubMedCrossRef Chott A, Haedicke W, Mosberger I et al (1998) Most CD56+ intestinal lymphomas are CD8+ CD5 T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol 153:1483–1490PubMedCrossRef
9.
Zurück zum Zitat Cellier C, Delabesse E, Helmer C et al (2000) Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. Lancet 356:203–208PubMedCrossRef Cellier C, Delabesse E, Helmer C et al (2000) Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. Lancet 356:203–208PubMedCrossRef
10.
Zurück zum Zitat Daum S, Weiss D, Hummel M et al (2001) Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue. Gut 49:804–812PubMedCrossRef Daum S, Weiss D, Hummel M et al (2001) Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue. Gut 49:804–812PubMedCrossRef
11.
Zurück zum Zitat Das DK, Gupta SK, Ayyagari S et al (1987) Pleural effusion in Non-Hodgkin’s lymphoma. A cytomorphologic, cytochemical and immunologic study. Acta Cytol 31:119–124PubMed Das DK, Gupta SK, Ayyagari S et al (1987) Pleural effusion in Non-Hodgkin’s lymphoma. A cytomorphologic, cytochemical and immunologic study. Acta Cytol 31:119–124PubMed
12.
Zurück zum Zitat Das DK (2006) Serous effusions in malignant lymphomas: a review. Diagn Cytopathol 34:335–347PubMedCrossRef Das DK (2006) Serous effusions in malignant lymphomas: a review. Diagn Cytopathol 34:335–347PubMedCrossRef
13.
Zurück zum Zitat Mihaescu A, Gebhard S, Chaubert P et al (2002) Application of molecular genetics to the diagnosis of lymphoid-rich effusions: Study of 95 cases with concomitant immunophenotyping. Diagn Cytopathol 27:90–95PubMedCrossRef Mihaescu A, Gebhard S, Chaubert P et al (2002) Application of molecular genetics to the diagnosis of lymphoid-rich effusions: Study of 95 cases with concomitant immunophenotyping. Diagn Cytopathol 27:90–95PubMedCrossRef
14.
Zurück zum Zitat Lundqvist C, Baranov V, Hammarström S et al (1995) Intra-epithelial lymphocytes. Evidence for regional specialization and extrathymic T cell maturation in the human gut epithelium. Int Immunol 7:1473–1487PubMedCrossRef Lundqvist C, Baranov V, Hammarström S et al (1995) Intra-epithelial lymphocytes. Evidence for regional specialization and extrathymic T cell maturation in the human gut epithelium. Int Immunol 7:1473–1487PubMedCrossRef
15.
Zurück zum Zitat Gorfu G, Rivera-Nieves J, Ley K (2009) Role of β7 integrins in intestinal lymphocyte homing and retention. Curr Mol Med 9:836–850PubMedCrossRef Gorfu G, Rivera-Nieves J, Ley K (2009) Role of β7 integrins in intestinal lymphocyte homing and retention. Curr Mol Med 9:836–850PubMedCrossRef
16.
Zurück zum Zitat Deleeuw RJ, Zettl A, Klinker E et al (2007) Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 132:1902–1911PubMedCrossRef Deleeuw RJ, Zettl A, Klinker E et al (2007) Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 132:1902–1911PubMedCrossRef
Metadaten
Titel
A case of enteropathy-associated T-cell lymphoma: diagnosis by flow cytometric immunophenotyping and genome analysis using ascitic fluid
verfasst von
Masako Nishimura
Kenjiro Tomo
Publikationsdatum
01.12.2011
Verlag
Springer Japan
Erschienen in
International Journal of Clinical Oncology / Ausgabe 6/2011
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-011-0252-0

Weitere Artikel der Ausgabe 6/2011

International Journal of Clinical Oncology 6/2011 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.